Journal of Clinical PracticeJournal of Clinical PracticeКлиническая практика2220-30952618-8627Eco-Vector901910.17816/clinpract8476-89ArticlesСтатьиReview ArticleTACHYARRHYTHMIAS IN PATIENTS WITH CANCERТАХИАРИТМИИ У ПАЦИЕНТОВ С ОНКОЛОГИЧЕСКИМИ ЗАБОЛЕВАНИЯМИChelombit'koE GЧеломбитькоЕкатерина Геннадьевна

врач-кардиолог кардиологического отделения лечения нарушений ритма сердца

cardio@fnkc-fmba.ruKorolevS VКоролевСергей Владимирович

к.м.н, заведующий отделением хирургического лечения сложных нарушений ритма сердца и ЭКС

cardio@fnkc-fmba.ruKonevA VКоневАлексей Васильевич

к.м.н., заведующий кардиологическим отделением лечения нарушений ритма сердца

konevalexv@mail.ruPlokhovaE VПлоховаЕкатерина Владимировна

к.м.н, врач-кардиолог кардиологического отделения

evplokhova@gmail.comDoundouaD PДундуаДавид Петрович

д.м.н., руководитель кардиологического центра

dundua.dp@fnkc-fmba.ruФедеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий ФМБА России1512201784NO4 (2017)№4 (2017)768926062018Copyright ©; 2017, Chelombit'ko E.G., Korolev S.V., Konev A.V., Plokhova E.V., Doundoua D.P.Copyright ©; 2017, Челомбитько Е.Г., Королев С.В., Конев А.В., Плохова Е.В., Дундуа Д.П.2017Chelombit'ko E.G., Korolev S.V., Konev A.V., Plokhova E.V., Doundoua D.P.Челомбитько Е.Г., Королев С.В., Конев А.В., Плохова Е.В., Дундуа Д.П.https://creativecommons.org/licenses/by-nc-nd/4.0https://clinpractice.ru/clinpractice/article/view/9019

Arrhythmia is often detected in cancer patient, from single ventricular premature contractions to sustained ventricular tachycardia, life threatening ventricular fibrillation and sudden cardiac death. Oncology per se, aggressive anticancer treatment, both chemotherapy and radiation and basic cardiac conditions are main causative factors for tachyarrhythmia. In this review we summarize evidence of arrhythmia and emphasize the importance of cardiac monitoring for the early diagnosis, intervention and surveillance of those patients more susceptible to develop proarrhythmia. Oncologists should be fully aware of arrhythmia and the close collaboration between cardiologists and oncologists would result in a better cardiovascular assessment, risk stratification, cardiac monitoring and treatment.

Аритмии часто выявляют у онкологических больных, получающих лечение. Они разнообразны: от единичных перебоев и легкого сердцебиения до жизнеугрожающих нарушений ритма или даже внезапной сердечной смерти (ВСС). Нарушения ритма сердца могут приводить к сердечной недостаточности, травмам при потере сознания, или кардиоэмболическому инсульту при фибрилляции предсердий, внося существенные коррективы в схему лечения больного. Аритмия у больного с раком не имеет каких-либо отличительных особенностей, но может быть непосредственно связана со злокачественным новообразованием, индуцирована химиотерапевтическим препаратом или же возникать на фоне имеющегося заболевания сердечно-сосудистой системы. В предлагаемом обзоре рассматриваются нарушения ритма по типу тахиаритмий, чаще всего встречающиеся у онкологических пациентов, а также их особенности, характерные непосредственно для онкологических заболеваний, и подчеркивается важность мониторирования ЭКГ для ранней диагностики, лечения и наблюдения за данной когортой пациентов, которые более восприимчивы к развитию проаритмии. Онкологи должны быть в полной мере осведомлены о возможных нарушениях ритма сердца, и тесное сотрудничество между кардиологами и онкологами приведет к лучшей стратификации риска развития сердечно-сосудистых заболеваний, мониторингу и лечению.

tachyarrhythmiaoncologychemotherapyarrhythmogenic actionsupraventricular tachycardiaventricular tachycardiacardiooncologycardiotoxicityтахиаритмияонкологияхимиотерапияаритмогенное действиесуправентрикулярная тахикардияжелудочковая тахикардиякардиоонкологиякардиотоксичностьBeheiry, S., Al-Ahmad, A., & Natale, A. (2011). Atrial fibrillation and flutter: Diagnosis and treatment. In A. Tsiperfal, L.K. Ottoboni, S. Beheiry, A.Al-Ahmad, A. Natale, & P. Wang (Eds.), Cardiac arrhythmia management: A practical guide for nurses and allied professionals (pp. 85-100). Chichester, West Sussex, UK: Wiley-Blackwell.Chugh, S.S., Blackshear, J.L., Shen, W.K., Hammill, S.C., & Gersh, B.J. (2001). Epidemiology and natural history of atrial fibrillation: Clinical implications. Journal of the American College of Cardiology, 37,371-378.Ciriaco, P., Mazzone, P., Canneto, B., & Zannini, P. (2000). Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone. European Journal of Cardio-Thoracic Surgery, 18,12-16.Epstein, A.E., DiMarco, J.P., Ellenbogen, K.A., Estes, N.A., 3rd, Freedman, R.A., Gettes, L.S.,Yancy, C.W. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 51(21), el-e62.Falk, R.H., & Dubrey, S.W. (2010). Amyloid heart disease. In M.A. Gertz & S.V. Rajkumar (Eds.), Amyloidosis: Diagnosis and treatment (pp. 107-128). New York, NY: Humana Press.Fuster, V., Ryden, L.E., Asinger, R.W., Cannom, D.S., Crijns, H.J., Frye, R.L.,Torbicki. A. (2001). АСС/ AHA/LSC guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation, 104, 2118-2150.Fuster, V. Ryden, L.E. Cannom, D.S., Crijns, H.J. Curtis, A.B., Ellenbogen, K.A., Wann, L.S., (2011). 2011ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines developed In partnership with die European Society of Cardiology and In collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Journal of the American College of Cardiology, 57, el01-el98.Go, A.S., Hylek, E.M., Phillips, K.A., Chang, Y., Henault, L.E., Selby, J.V., & Singer, D.E. (2001). Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 285, 2370-2375.Granada, J., Uribe, W., Chyou, P.H., Maassen, K., Vierkant, R., Smith, P.N., Vidaillet, H. (2000). Incidence and predictors of atrial flutter in the general population. Journal of the American College of Cardiology, 36, 2242-2246.Hidalgo,J.D., Krone, R., Rich, M.W., Blum, K., Adkins, D., Fan, M.Y., Khoury, H. (2004). Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: Incidence, risk factors and outcomes. Bone Marrow Transplantation, 34, 615-619.Hollings, D.D., Higgins, R.S.D., Faber, L.P., Warren, W.H., Liptay, M.J., Basu, S., & Kim, A.W. (2010). Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy. American Journal of Surgery, 199,558-561.Ma, J.-Y., Wang, Y., Zhao, Y.-E, Wu, Z„ Liu, L.-X., Kou, Y.-L., & Yang, J.J. (2006). Atrial fibrillation after surgery for esophageal carcinoma: Clinical and prognostic significance. World Journal of Gastroenterology, 12, 449-452.Menard, O., Martinet, Y., & Lamy, P. (1991). Cisplatin-induced atrial fibrillation. Journal of Clinical Oncology, 9, 192-193.Miller, J.M., & Zipes, D.P. (2012). Therapy for cardiac arrhythmias. In R.O. Bonow, D.L. Mann, D.P. Zipes, & P. Libby (Eds.), Braunwald’s heart disease: A textbook of cardiovascular medicine (9th ed., pp.771-823). Philadelphia, W.B.:Saunders.Montella, L., Caraglia, M., Addeo, R., Costanzo, R., Faiola, V., Abbruzzese, A,, & Del Prete, S. (2005). Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert’s disease). Annals of Hematology, 84,192-193.Murthy, S.C., Law, S. Whooley, B.P., Alexandrou, A., Chu, K.-M., & Wong, J. (2003). Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. Journal of Thoracic and Cardiovascular Surgery, 126, 1162-1167.Olgin, J., & Zipes, D.P. (2012). Therapy for cardiac arrhythmias. In R.O. Bonow, D.L. Mann, D.P. Zipes. & P.I. Libby (Eds.), Braunwald’s heart disease: A textbook of cardiovascular medicine (9th cd.,pp. 710-743). Philadelphia, W.B. Saunders.Olivieri, A., Corvatta, L., Montanari, M., Brunori, M., Offidani, M., Ferretti, G.F., Leoni, P. (1998). Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. Bone Marrow Transplantation, 21, 1049-1053.Olshansky, B., Rosenfeld, L.E., Warner, A.L., Solomon, A.J., O’Neill, G., Sharma, A., Greene, H.L. (2004). The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: Approaches to control rate in atrial fibrillation. Journal of the American College of Cardiology, 43, 1201-1208.Onaitis, M., D’Amico, T., Zhao, Y., O’Brien, S., & Harpole, D. (2010). Risk factors for atrial fibrillation after lung cancer surgery: Analysis of the Society of Thoracic Surgeons general thoracic surgery database. Annals of Thoracic Surgery, 90, 368-374.Palma, M., Mancuso, A., Grifalchi, F., Lugini, A., Pizzardi, N., & Cortesi, E. (2002). Atrial fibrillation during adjuvant chemotherapy with docetaxel: A case report. Tumori, 88, 527-529.Pappone, C., Vicedomini, G., Cremonesi, A., Zuffada, F., & Santinelli, V. (2011). Device-based left atrial appendage closure. Circulation: Arrhythmia and Electrophysiology, 4, 418-419.Roselli, E.E., Murthy, S.C., Rice, T.W., Houghtaling, P.L., Pierce, C.D., Karchmer, D.P., & Blackstone, E.H. (2005). Atrial fibrillation complicating lung cancer resection. Journal of Thoracic and Cardiovascular Surgery, 130, 438-444.Siu, C.-W., Tung, H.-M., Chu, K.-W., Jim, M.-H., Lau, C.-P., & Tse, H.-F. (2005). Prevalence and predictors of new-onset atrial fibrillation after elective surgery for colorectal cancer. Pacing and Clinical Electrophysiology, 28(Suppl. 1), S120-S123.Tavil, Y., Arslan, U., Okyay, K., Sen, N., & Boyaci, B. (2007). Atrial fibrillation induced by gemcitabine treatment in a 65-year-old man. [Case reports]. Onkologie, 30, 253-255.Wann, L.S., Curtis, A.B., January, C., Ellenbogen, K.A., Lowe, J.E., Estes, N.A., 3rd., Yancy, C.W. (2011b). 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline); A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines, Circulation, 121,104-123.